The Clorox Company (CLX) Stock Forecast
CLX analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 2.78 / 5 from 18 analysts
- Price target
- $97.24 average of analyst targets
- Upside to target
- +11.6% from the latest close
- Next earnings
- November 2, 2026 EPS estimate $0.99
- 52-week range
- $80.41 – $127.16
CLX analyst ratings
18 analystsNumber of analysts at each rating.
CLX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CLX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.08 | $0.81 | $1.20 | $0.85 | +27.3% | 15 |
| Next quarter (Dec '26) | $1.34 | $1.22 | $1.47 | $1.39 | −3.7% | 15 |
| Current fiscal year (FY2027) | $5.72 | $5.30 | $5.85 | $5.53 | +3.4% | 19 |
| Next fiscal year (FY2028) | $6.16 | $5.64 | $6.56 | $5.72 | +7.7% | 18 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CLX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.88B | $1.87B | $1.89B | +31.3% | 12 |
| Next quarter (Dec '26) | $1.89B | $1.87B | $1.91B | +13.0% | 12 |
| Current fiscal year (FY2027) | $7.63B | $7.59B | $7.67B | +13.6% | 16 |
| Next fiscal year (FY2028) | $7.82B | $7.67B | $7.93B | +2.5% | 15 |
CLX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CLX revenue: reported and forecast
CLX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.22 | $1.11 | $1.11 | $1.09 | $1.08 | −11.4% | 1 up · 5 down |
| Next quarter (Dec '26) | $1.39 | $1.37 | $1.36 | $1.34 | $1.34 | −3.4% | 2 up · 3 down |
| Current fiscal year (FY2027) | $6.02 | $5.82 | $5.79 | $5.75 | $5.72 | −5.1% | 0 up · 5 down |
| Next fiscal year (FY2028) | $6.54 | $6.36 | $6.26 | $6.21 | $6.16 | −5.8% | 0 up · 5 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CLX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CLX beat in 10 of 12.
What analysts expect from CLX
18 analysts cover Clorox; their consensus rating is hold (2.78 on a 1–5 scale, where 5 is a strong buy). The average price target is $97.24, 11.6% above the latest close of $87.09. Analysts expect earnings of $5.72 per share for FY2027, +3.4% from a year earlier. For FY2028 the average estimate is $6.16 per share on revenue of $7.8 billion. Clorox beat the EPS estimate in 10 of the last 12 quarters.
Related: CLX income statement, CLX key metrics, CLX chart. See the CLX stock overview for the latest quote and news.
CLX forecast FAQ
What is Clorox's price target?
The average analyst price target for Clorox is $97.24, 11.6% above the latest close of $87.09.
Is Clorox a buy, hold or sell?
Of 18 analysts covering Clorox, 1 rate it a strong buy, 0 a buy, 13 a hold, 2 a sell and 2 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Clorox's EPS forecast?
Analysts forecast $5.72 per share for FY2027 (range $5.30 to $5.85); for FY2028 the estimate is $6.16.
What is Clorox's revenue forecast?
The average revenue estimate for FY2027 is $7.6 billion, growth of 13.6%; for FY2028 it is $7.8 billion.
When does Clorox report earnings?
Clorox is expected to report results for the quarter ending September 30, 2026 on November 2, 2026 after the market closes; the EPS estimate is $0.99.
Does Clorox usually beat earnings estimates?
Clorox reported EPS at or above the analyst estimate in 10 of the last 12 quarters.